Loading...

Integrating immune checkpoint inhibitors and targeted therapies in the treatment of early stage non-small cell lung cancer: a narrative review

Prognosis of early stage non-small cell lung cancer (eNSCLC) is poor even when treated radically with surgery and (neo)adjuvant chemotherapy (Cht). The discovery of tyrosine kinase inhibitors (TKIs) for oncogene addicted NSCLC and immune checkpoint inhibitors (ICIs) have revolutionised the therapeut...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Transl Lung Cancer Res
Main Authors: Ortega-Franco, Ana, Calvo, Virginia, Franco, Fabio, Provencio, Mariano, Califano, Raffaele
Format: Artigo
Sprog:Inglês
Udgivet: AME Publishing Company 2020
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7815374/
https://ncbi.nlm.nih.gov/pubmed/33489825
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tlcr-20-546
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!